Stocks to Watch: VIASPACE Inc. (OTCBB: VSPC), Voyager Petroleum , Inc. (OTC BB:VYGO) , Cardima, Inc. (OTC BB:CADM) , Golden Eagle International, Inc. (OTC BB:MYNG), InNexus Biotechnology Inc. (OTC BB:IXSBF)
Featured Stock: VIASPACE Inc.
(OTCBB: VSPC)
Current Price (0.03)
VIASPACE CEO OUTLINES THE BILLION DOLLAR PROFIT POTENTIAL FOR FUEL CELL CARTRIDGES
PASADENA, CA — May 28, 2008—VIASPACE Inc. (OTCBB: VSPC) today provided a brief overview of both fuel cells as well as the business model for fuel cell cartridges which VIASPACE’s subsidiary, Direct Methanol Fuel Cell Corporation (“DMFCC”), is pursuing. VIASPACE and DMFCC CEO, Dr. Carl Kukkonen, states, “Fuel cartridges are the consumable in the fuel cell business. Fuel cells are like a razor with fuel cartridges as the razor blades. VIASPACE and DMFCC are helping to build a new industry that, while it does not exist today, has the potential to produce tens of billions of dollars in revenue over the next five years. “
“If the large portable electronic OEMs are successful in developing fuel cell powered portable electronics, five to 10 billion cartridges per year could be sold with potential profits exceeding $1 billion per year. There are plenty of risks, but the potential profits are huge.”
An overview of both fuel cells and the cartridges business model is outlined below.
1. Fuel cells are electrochemical engines that produce electricity directly from the fuel without burning. Electricity is made very efficiently and fuel cells are a green technology
2. The first market for fuel cells is likely to be in portable electronics. Compared to batteries, fuel cells enable a longer device operating time in addition to instant recharging, by replacing the disposable fuel cartridge without the need for an electrical plug and several hours to recharge. The convenience and increased productivity of new power-hungry portable electronic devices such as smart phones currently drives the market.
3. Direct methanol fuel cells seem to represent the fuel cell of choice by most portable electronics manufacturers. Samsung, Sony, Toshiba, Hitachi, Panasonic and other large OEMs have already demonstrated that notebook computers, mobile phones and other devices can be powered by direct methanol fuel cells. In fact, we believe that they are spending hundreds of millions of dollars to develop fuel cells and the products that use them.
4. International safety regulations developed by Underwriters Laboratories and the Japanese Electric Manufacturers Association have specified that a fuel must be contained in a safe, sealed and preferably disposable container called a cartridge. DMFCC is a member of these international committees.
5. With these safety regulations, the International Civil Aviation Organization and the US Department of Transportation have recently allowed direct methanol fuel cells and cartridges to be carried on airplanes by passengers and aircrew. This is a major breakthrough.
6. According to industry sources, there were 100 million notebook computers and 1.1 billion mobile phones produced worldwide in 2007, and these figures are projected to rise to 160 million notebooks and 1.8 billion mobile phones in about five years. If the OEMs succeed in their product offerings, it is projected that up to 22% of notebook computers and 2.5% of mobile phones will be powered by fuel cells in about five years. This leads to a projection of 91 million fuel cell powered devices sold. Independently, Frost and Sullivan have projected that 71 million fuel cell powered portable electronic devices will likely be sold in 2011. OEMs are currently spending hundreds of millions of dollars to try and capture this large new market.
7. Each notebook computer and mobile phone powered by a fuel cell is projected to use between two and four cartridges per month over its three-year lifetime. If the OEMs are successful, this level of cartridge usage amounts to five to 10 billion cartridges per year, approximately five years from introduction. This is the market that DMFCC is pursuing.
8. While specific cartridge pricing has not yet been determined, cartridges are projected to sell for between $3.00 and $5.00 each, and the overall cartridge industry could be worth as much as $15 billion to $30 billion per year at the retail level. Consequently, cartridge manufacturing and distribution profits could be in the billions of dollars per year. That is why DMFCC is in the cartridge business.
9. DMFCC has an established global network of qualified cartridge manufacturing partners that are already trusted suppliers to many OEMs. DMFCC is already working with Samsung and other companies on cartridges.
10. The OEMs want to sell notebook computers and mobile phones and, while most do not want to manufacture and sell cartridges, they do want cartridges to be widely available. DMFCC's investment cost in the cartridge business is much lower than the costs being expended by OEMs on developing the fuel cells. DMFCC’s manufacturing partners are also sharing in the cartridge development costs.
11. In addition to providing cartridges, DMFCC also has the patents on direct methanol fuel cells that most OEMs will need to bring their DMFC products to market. DMFCC has stated that they are willing to provide this patent protection to the OEMs in exchange for a cartridge supply agreement. This is another incentive for OEMs to work directly with DMFCC.
12. DMFCC is, nonetheless, dependent on the OEMs’ success in bringing fuel cell powered portable electronics to the marketplace. In order to benefit from their success, DMFCC must be willing to take these risks together with the OEMs.
About VIASPACE: Originally founded in 1998 with the objective of transforming proven space and defense technologies from NASA and the Department of Defense into hardware and software solutions that solve today's complex problems, VIASPACE benefits from important patent and software licenses from Caltech, which manages NASA’s Jet Propulsion Laboratory. For more information, please visit our website at www.VIASPACE.com, or contact for Investor Relations, Dr. Jan Vandersande, Director of Communications at 800-517-8050, or IR@VIASPACE.com.
Press contact: Carl Kukkonen 626-768-3360
-----------------------------
This news release includes forward-looking statements. These forward-looking statements relate to future events or our future performance and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. Such factors include the risks outlined in our periodic filings with the U.S. Securities and Exchange Commission, including our Annual Report on Form 10-KSB, for the fiscal year ended December 31, 2007, as well as general economic and business conditions, the ability to acquire and develop specific projects and technologies, the ability to fund operations, changes in consumer and business consumption habits, and other factors over which VIASPACE has little or no control.
For an in-depth analyst report, please visit : www.WallStreetStockReview.com
Voyager Petroleum , Inc.
(OTC BB:VYGO)
Current Price (0.02)
www.WallStreetStockReview.com
HINSDALE, Ill., May 29, 2008 -- Voyager Petroleum, Inc. (OTC BB:VYGO.OB - News) (Frankfurt:DXD.F - News) is pleased to announce that Monarch Petroleum, its wholly-owned subsidiary, has secured its initial sale of a reclaimed used oil product out of its Detroit facility with a major Midwest distributor of petroleum-based lubricants. The parties are working closely to establish a long-term relationship that will be beneficial for both companies. The company is marketing its eco-friendly re-processing method for reclaimed used oil and working diligently to inform regional automotive and industrial customers in the Midwest of its processing capabilities. Sebastien C. DuFort, the Company's CEO, commented, ``We now intend to focus our efforts on revenue-producing activities by building our customer base and solidifying our independent sales force as we progress towards expanded operations at the Detroit facility.'' Voyager Petroleum seeks to acquire reputable middle market petroleum based lubricant companies that refine, blend, bottle, and distribute to the automotive and manufacturing after market with established regional distribution channels and experienced management that would recognize increased revenue and significant cost savings from an injection of working capital, wider distribution, or vertical integration.
Cardima, Inc.
(OTC BB:CADM)
Current Price (1.05)
www.WallStreetStockReview.com
FREMONT, CA----May 29, 2008 -- Cardima, Inc. (OTC BB:CADM.OB - News) has announced a new strategic marketing relationship with Dot Medical Ltd., a United Kingdom (UK) distributor specializing in sales and customer training and support for Cardiac Devices. Dot Medical is the leading independent UK distributor for medical devices used to treat cardiac arrhythmias. Dot Medical supports and trains Electrophysiologists in the UK, both in the National Healthcare System (NHS) and private hospitals. Dot's staff is composed of both sales and clinical training specialists who directly support Cardiac Cath Labs, assisting Electrophysiologist with procedures, and providing solutions for patient care. The UK, like other European countries, faces difficulties in effectively treating large number of patients with Atrial Fibrillation (AF) due to the length of time and complexity of current procedures. The Cardima EP Ablation System, which incorporates the REVELATION® T-Flex and the INTELLITEMP®, will assist in meeting the needs of patients with AF and physicians who treat them. Cardima, Inc. has developed the PATHFINDER® Series of diagnostic catheters, the REVELATION® Series of ablation catheters, the INTELLITEMP® Energy Management Device, and the Surgical Ablation System (SAS). All of these devices are CE marked and received U.S. FDA 510(k) clearance. The REVELATION® Series with the INTELLITEMP® EP Energy Management Device was developed for the treatment of atrial fibrillation (AF) and received CE mark approval in Europe, however, is not currently available in the U.S.
Golden Eagle International, Inc.
(OTC BB:MYNG)
Current Price (0.006)
www.WallStreetStockReview.com
SALT LAKE CITY, UT---May 30, 2008 -- Golden Eagle International, Inc. (OTC BB:MYNG.OB - News) today reported that it is in the final stage of construction of its C Zone gold mill in eastern Bolivia. The Company estimates that the C Zone gold mill will begin its preliminary shake-out operations within the first 10 days of June and will commence its initial production phase at 200 tpd of mineralized material before the end of June 2008. Golden Eagle intends to incrementally expand its C Zone gold mill over the first 6 months of operations to a final projected capacity of 2,000 tpd. Golden Eagle International, Inc. is a gold and copper exploration and mining company headquartered in Salt Lake City, Utah and with offices also in Santa Cruz, Bolivia. The Company is concentrating its efforts on expanding its pilot operations into production operations on its gold project on the C Zone within its 136,500 acres (213 square miles) in eastern Bolivia's Precambrian Shield. In addition, the Company is working with Washington Group International, Inc. on a due diligence study on the Company's A Zone Buen Futuro gold and copper project.
InNexus Biotechnology Inc.
(OTC BB:IXSBF)
Current Price (0.27)
www.WallStreetStockReview.com
BRITISH COLUMBIA, Canada--May 30--InNexus Biotechnology Inc. (OTCBB:IXSBF - News) (TSX VENTURE:IXS - News) (http://www.ixsbio.com), a drug development company commercializing the next generation of monoclonal antibodies based on its technology, Dynamic Cross Linking (DXL™), announced today that due to extensive interest in the brokered Private Placement led by Dundee Securities Corporation announced on 23 May 2008, the Company is pleased to announce that the offering has been increased to 20,000,000 units with gross proceeds of up to $5,000,000. InNexus is a drug development company commercializing the next generation of monoclonal antibodies based on its Dynamic Cross Linking (DXL™) technology, which improves the potency of existing antibody products while opening new markets and disease applications. DXL™ antibodies utilize unique, novel, and patented methods and technologies of InNexus.
WallStreetStockReview.com is owned and operated by Iron Consulting LLC
Verify all claims and do your own due diligence. Iron Consulting profiles are not a solicitation or recommendation to buy, sell or hold securities. Iron Consulting is not offering securities for sale. An offer to buy or sell can be made only with accompanying disclosure documents and only in the states and provinces for which they are approved. All statements and expressions are the sole opinion of the editor and are subject to change without notice. Iron Consulting is not liable for any investment decisions by its readers or subscribers. It is strongly recommended that any purchase or sale decision be discussed with a financial adviser, or a broker-dealer, or a member of any financial regulatory bodies. The information contained herein has been provided as an information service only. The accuracy or completeness of the information is not warranted and is only as reliable as the sources from which it was obtained. It should be understood there is no guarantee that past performance will be indicative of future results. Investors are cautioned that they may lose all or a portion of their investment in this or any other company. In order to be in full compliance with the Securities Act of 1933, Section 17(b), WallStreetStockReview.com is owned and operated by Iron Consulting. Iron Consulting www.ironconsultinginc.com has previously been paid two hundred and twenty three thousand dollars from Equity Alliance Intl. for a one year three month program and a additional ninety five thousand for current six month coverage starting March 1, 2008, from Equity Alliance Int. LLC www.equityallianceir.com for its marketing and consulting services. Neither Iron Consulting nor any of its affiliates, or employees shall be liable to you or anyone else for any loss or damages from use of this e-mail, caused in whole or part by its negligence or contingencies beyond its control in procuring, compiling, interpreting, reporting, or delivering this Web Site or e-mail and any contents. Since Iron Consulting receives compensation and its employees or members of their families may hold stock in the profiled companies, there is an inherent conflict of interest in Iron Consulting statements and opinions and such statements and opinions cannot be considered independent. Iron Consulting and its management may benefit from any increase in the share prices of the profiled companies. Information contained herein contains "forward looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities and Exchange Act of 1934. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical facts and may be "forward looking statements". Forward looking statements are based on expectations, estimates and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Iron Consulting services are often paid for using free-trading shares. Iron Consulting may be selling shares of stock at the same time the profile is being disseminated to potential investors; this should be viewed as a definite conflict of interest and as such, the reader should take this into consideration.
